ANTERIS TECHNOLOGIES CDI 1:1 USPROHIBITED (AVR) Short Interest
ANTERIS TECHNOLOGIES CDI 1:1 USPROHIBITED (ASX:AVR) had 0.00% of shares reported as short positions as of 16 July 2026, representing 5 shares. ANTERIS TECHNOLOGIES CDI 1:1 USPROHIBITED operates in the Health Care Equipment & Services industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Anteris Technologies Global Corp.
Anteris Technologies Ltd specializes in developing advanced heart valve technologies, focusing on delivering innovative solutions to address unmet medical needs in cardiac surgery. Positioned as a frontrunner in the heart valve market, Anteris leverages its proprietary ADAPT tissue technology and DurAVR 3D single-piece aortic heart valves to enhance patient outcomes. The company's unique value lies in its commitment to revolutionizing cardiovascular care with cutting-edge scientific research and development.
Short position
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4AVR intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Anteris Technologies Global Corp.
About
website
address
More Health Care Equipment & Services Stocks
Other shorted stocks in this sector
Be the first to discuss AVR
Start a research thread or post the first pulse update